<DOC>
	<DOCNO>NCT01618591</DOCNO>
	<brief_summary>The purpose trial develop evidence relative efficacy 3 available single-dose loperamide adjuncted regimen watery diarrhea single-dose regimen , without loperamide , dysentery/febrile diarrhea require informing decision among regimen . Information study use develop management guideline diagnosis management traveler ' diarrhea ( TD ) among deploy United States United Kingdom military personnel .</brief_summary>
	<brief_title>Trial Evaluating Ambulatory Treatment Travelers ' Diarrhea</brief_title>
	<detailed_description>The study multi-site , randomize , double-blind , control clinical trial among ambulatory deploy personnel . Patients present care clinically assess determination make whether acute watery diarrhea ( AWD ) acute dysentery/febrile diarrhea ( ADF ) . For AWD arm , patient randomize receive 1 3 regimen : ( 1 ) rifaximin 1650 mg single dose plus loperamide 4 mg initially follow 2 mg unformed stool , exceed 16 mg/day 2 day ( 120 subject ) ; ( 2 ) azithromycin 500 mg single dose plus loperamide 4 mg initially follow 2 mg unformed stool , exceed 16 mg/day 2 day ( 120 subject ) ; ( 3 ) levofloxacin 500 mg single dose plus loperamide 4 mg initially follow 2 mg unformed stool , exceed 16 mg/day 2 day ( 120 subject ) . For ADF arm , patient randomize receive 1 2 regimen : ( 1 ) azithromycin 1000 mg single dose plus loperamide 4 mg initially follow 2 mg unformed stool , exceed 16 mg/day 2 day ( 75 subject ) ; ( 2 ) azithromycin 1000 mg single dose without loperamide ( 75 subject ) . Study Procedures ( Brief ) : Baseline exam well blood stool sample collect initial clinic visit . Clinical assessment perform 24 hour , 72 hour , 7 day . In addition , microbiological cure evaluate 7-d post initiation treatment . Subjects blood drawn ass serological conversion common enteric pathogen , stool collect 7- 21-d . Subjects may also opt long-term follow-up time enrollment , assess development post-infectious functional bowel disorder . All subject complete baseline assessment 7-d visit , opt additional follow-up complete series web-based survey 3- , 6- , 9- , 12-m post enrollment .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>1 . Active duty military military beneficiary , 18 yearsold old . 2 . Presence acute diarrhea ( 3 stool 24 hour 2 stool 24 hour associate symptom nausea , vomit , abdominal cramp tenesmus ) &lt; 96 hour duration . 3 . Eligible ambulatory management . 4 . Able comply followup procedure . 5 . Will remain country least 7 day 1 . Allergy rifamycins , quinolones , macrolides , loperamide ( include mild gastrointestinal upset ) . 2 . Antibiotic therapy 72 hour prior presentation ( exclude malaria prophylaxis mefloquine , malarone , chloroquine/proguanil , doxycycline ) . 3 . Concomitant medication know drugdrug interaction study drug ( include theophylline , digoxin , warfarin ) . 4 . History seizure ( relative contraindication quinolones ) 5 . Positive pregnancy test presentation ( contraindicate fluoroquinolone therapy ) . All female subject administer urine pregnancy test prior enrollment . 6 . Presence symptom &gt; 96 hour prior initiate treatment . 7 . Use &gt; 4 mg loperamide use amount loperamide great 24 hour prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>diarrhea</keyword>
	<keyword>traveler ' diarrhea</keyword>
	<keyword>watery diarrhea</keyword>
	<keyword>enteric illness</keyword>
	<keyword>dysentery</keyword>
	<keyword>gastrointestinal</keyword>
</DOC>